On June 23, XZenith welcomed a group of three experts from Beijing Municipal Medical Products Administration to carry out on-site inspection of Drug Manufacturing Certificate application.

This inspection is the first inspection of XZenith as a drug marketing authorization holder, and the product involved is class 1 innovative drug ，Anaprazole Sodium Enteric-coated Tablets. Three experts from Beijing Municipal Medical Products Administration carried out a comprehensive and systematic inspection from many aspects, such as personnel, organizational structure, quality system operation, and commissioned production management. Our company staff are fully prepared, solid business, highly recognized by the inspection experts, the inspection was successfully completed. The successful completion of the inspection is of great significance, marking the XZenith from research and development enterprises to R&D, production, sales of integrated enterprises have taken a solid step.